Cardiol Therapeutics Inc. (CRDL)
Total Valuation
CRDL has a market cap or net worth of $58.23 million. The enterprise value is $17.14 million.
Market Cap | 58.23M |
Enterprise Value | 17.14M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, after market close.
Earnings Date | Nov 14, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
CRDL has 65.11 million shares outstanding. The number of shares has increased by 3.45% in one year.
Shares Outstanding | 65.11M |
Shares Change (YoY) | +3.45% |
Shares Change (QoQ) | +0.60% |
Owned by Insiders (%) | 4.42% |
Owned by Institutions (%) | 14.55% |
Float | 62.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.29, with a Debt / Equity ratio of 0.01.
Current Ratio | 5.29 |
Quick Ratio | 5.08 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.40% and return on invested capital (ROIC) is -88.02%.
Return on Equity (ROE) | -65.40% |
Return on Assets (ROA) | -54.70% |
Return on Capital (ROIC) | -88.02% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.71% in the last 52 weeks. The beta is 0.95, so CRDL's price volatility has been similar to the market average.
Beta (1Y) | 0.95 |
52-Week Price Change | +77.71% |
50-Day Moving Average | 0.84 |
200-Day Moving Average | 0.76 |
Relative Strength Index (RSI) | 55.89 |
Average Volume (30 Days) | 224,815 |
Short Selling Information
The latest short interest is 255,145, so 0.39% of the outstanding shares have been sold short.
Short Interest | 255,145 |
Short Previous Month | 309,466 |
Short % of Shares Out | 0.39% |
Short % of Float | 0.41% |
Short Ratio (days to cover) | 0.82 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -30.85M |
Pretax Income | -28.01M |
Net Income | -28.01M |
EBITDA | -27.77M |
EBIT | -28.01M |
Earnings Per Share (EPS) | -$0.43 |
Balance Sheet
The company has $40.54 million in cash and $181,206 in debt, giving a net cash position of $40.36 million or $0.62 per share.
Cash & Cash Equivalents | 40.54M |
Total Debt | 181,206 |
Net Cash | 40.36M |
Net Cash Per Share | $0.62 |
Equity / Book Value | 34.87M |
Book Value Per Share | 0.54 |
Working Capital | 34.42M |
Cash Flow
In the last 12 months, operating cash flow was -$27.64 million and capital expenditures -$101,436, giving a free cash flow of -$27.74 million.
Operating Cash Flow | -27.64M |
Capital Expenditures | -101,436 |
Free Cash Flow | -27.74M |
FCF Per Share | -$0.43 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRDL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -48.71% |
FCF Yield | -48.24% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.45% |
Shareholder Yield | -3.45% |
Analyst Forecast
The average price target for CRDL is $4.50, which is 403.19% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.50 |
Price Target Difference | 403.19% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |